The National Institutes of Health (NIH) established the National Center for Advancing Translational Sciences (NCATS) in 2011 to "…pursue opportunities for disruptive translational innovation." 1 Through its extramural awards and internal research programs, NCATS is serving as this productive disruptor of research processes by catalyzing the development of innovative methods, approaches, and technologies to advance translational science. 2 Translational science aims to develop solutions to the longstanding challenges or bottlenecks that stymie progress of all research along the translational spectrum. 2 Examples of these solutions include approaches to derisking undruggable targets or untreatable diseases, developing more predictive in vitro and in vivo models of efficacy and toxicity, improving methods for clinical trial recruitment and diversification of trial participants, and enhancing recognition for scientists who participate in large cross-disciplinary research teams. [3][4][5][6] Through developing and disseminating evidence-informed practices that overcome these challenges, translational science approaches are benefiting all research that aims to improve